Search

The World Health Organization (WHO), in their 2022 report, identified cancer as one of the leading causes of death, accounting for about 16% of deaths worldwide. The Cancer-Moonshot community aims to reduce the cancer death rate by half in the next 25 years and wants to improve the lives of cancer-affected people. Cancer mortality can be reduced if detected early and treated appropriately. Cancers like breast cancer and cervical cancer have high cure probabilities when treated early in accordance with best practices. Integration of artificial intelligence (AI) into cancer research is currently addressing many of the challenges where medical experts fail to bring cancer to control and cure, and the outcomes are quite encouraging. AI offers many tools and platforms to facilitate more understanding and tackling of this life-threatening disease. AI-based systems can help pathologists in diagnosing cancer more accurately and consistently, reducing the case error rates. Predictive-AI models can estimate the likelihood for a person to get cancer by identifying the risk factors. Big data, together with AI, can enable medical experts to develop customized treatments for cancer patients. The side effects from this kind of customized therapy will be less severe in comparison with the generalized therapies. However, many of these AI tools will remain ineffective in fighting against cancer and saving the lives of millions of patients unless they are accessible and understandable to biologists, oncologists, and other medical cancer researchers. This paper presents the trends, challenges, and future directions of AI in cancer research. We hope that this paper will be of help to both medical experts and technical experts in getting a better understanding of the challenges and research opportunities in cancer diagnosis and treatment. [ABSTRACT FROM AUTHOR]

Breast cancer is one of the most prevalent cancers among women worldwide, and early detection of the disease can be lifesaving. Detecting breast cancer early allows for treatment to begin faster, increasing the chances of a successful outcome. Machine learning helps in the early detection of breast cancer even in places where there is no access to a specialist doctor. The rapid advancement of machine learning, and particularly deep learning, leads to an increase in the medical imaging community's interest in applying these techniques to improve the accuracy of cancer screening. Most of the data related to diseases is scarce. On the other hand, deep-learning models need much data to learn well. For this reason, the existing deep-learning models on medical images cannot work as well as other images. To overcome this limitation and improve breast cancer classification detection, inspired by two state-of-the-art deep networks, GoogLeNet and residual block, and developing several new features, this paper proposes a new deep model to classify breast cancer. Utilizing adopted granular computing, shortcut connection, two learnable activation functions instead of traditional activation functions, and an attention mechanism is expected to improve the accuracy of diagnosis and consequently decrease the load on doctors. Granular computing can improve diagnosis accuracy by capturing more detailed and fine-grained information about cancer images. The proposed model's superiority is demonstrated by comparing it to several state-of-the-art deep models and existing works using two case studies. The proposed model achieved an accuracy of 93% and 95% on ultrasound images and breast histopathology images, respectively. [ABSTRACT FROM AUTHOR]

Automatic brain tumor detection in MR Images is one of the basic applications of machine vision in medical image processing, which, despite much research, still needs further development. Using multiple machine learning techniques as an ensemble system is one of the solutions that can be effective in achieving this goal. In this paper, a novel method for diagnosing brain tumors by combining data mining and machine learning techniques has been proposed. In the proposed method, each image is initially pre-processed to eliminate its background region and identify brain tissue. The Social Spider Optimization (SSO) algorithm is then utilized to segment the MRI Images. The MRI Images segmentation allows for a more precise identification of the tumor region in the image. In the next step, the distinctive features of the image are extracted using the SVD technique. In addition to removing redundant information, this strategy boosts the speed of the processing at the classification stage. Finally, a combination of the algorithms Naïve Bayes, Support vector machine and K-nearest neighbor is used to classify the extracted features and detect brain tumors. Each of the three algorithms performs feature classification individually, and the final output of the proposed model is created by integrating the three independent outputs and voting the results. The results indicate that the proposed method can diagnose brain tumors in the BRATS 2014 dataset with an average accuracy of 98.61%, sensitivity of 95.79% and specificity of 99.71%. Additionally, the proposed method could diagnose brain tumors in the BTD20 database with an average accuracy of 99.13%, sensitivity of 99% and specificity of 99.26%. These results show a significant improvement compared to previous efforts. The findings confirm that using the image segmentation technique, as well as the ensemble learning, is effective in improving the efficiency of the proposed method. [ABSTRACT FROM AUTHOR]

Brain tumors (BTs) are deadly diseases that can strike people of every age, all over the world. Every year, thousands of people die of brain tumors. Brain-related diagnoses require caution, and even the smallest error in diagnosis can have negative repercussions. Medical errors in brain tumor diagnosis are common and frequently result in higher patient mortality rates. Magnetic resonance imaging (MRI) is widely used for tumor evaluation and detection. However, MRI generates large amounts of data, making manual segmentation difficult and laborious work, limiting the use of accurate measurements in clinical practice. As a result, automated and dependable segmentation methods are required. Automatic segmentation and early detection of brain tumors are difficult tasks in computer vision due to their high spatial and structural variability. Therefore, early diagnosis or detection and treatment are critical. Various traditional Machine learning (ML) techniques have been used to detect various types of brain tumors. The main issue with these models is that the features were manually extracted. To address the aforementioned insightful issues, this paper presents a hybrid deep transfer learning (GN-AlexNet) model of BT tri-classification (pituitary, meningioma, and glioma). The proposed model combines GoogleNet architecture with the AlexNet model by removing the five layers of GoogleNet and adding ten layers of the AlexNet model, which extracts features and classifies them automatically. On the same CE-MRI dataset, the proposed model was compared to transfer learning techniques (VGG-16, AlexNet, SqeezNet, ResNet, and MobileNet-V2) and ML/DL. The proposed model outperformed the current methods in terms of accuracy and sensitivity (accuracy of 99.51% and sensitivity of 98.90%). [ABSTRACT FROM AUTHOR]

Prostate cancer is a widespread form of cancer that affects patients globally and is challenging to diagnose, especially in its early stages. The common means of diagnosing cancer involve mostly invasive methods, such as the use of patient's blood as well as digital biopsies, which are relatively expensive and require a considerable amount of expertise. Studies have shown that various cancer biomarkers can be present in urine samples from patients who have prostate cancers; this paper aimed to leverage this information and investigate this further by using urine samples from a group of patients alongside FTIR analysis for the prediction of prostate cancer. This investigation was carried out using three sets of data where all spectra were preprocessed with the linear series decomposition learner (LSDL) and post-processed using signal processing methods alongside a contrast across nine machine-learning models, the results of which showcased that the proposed modeling approach carries potential to be used for clinical prediction of prostate cancer. This would allow for a much more affordable and high-throughput means for active prediction and associated care for patients with prostate cancer. Further investigations on the prediction of cancer stage (i.e., early or late stage) were carried out, where high prediction accuracy was obtained across the various metrics that were investigated, further showing the promise and capability of urine sample analysis alongside the proposed and presented modeling approaches. [ABSTRACT FROM AUTHOR]

Many patients affected by breast cancer die every year because of improper diagnosis and treatment. In recent years, applications of deep learning algorithms in the field of breast cancer detection have proved to be quite efficient. However, the application of such techniques has a lot of scope for improvement. Major works have been done in this field, however it can be made more efficient by the use of transfer learning to get impressive results. In the proposed approach, Convolutional Neural Network (CNN) is complemented with Transfer Learning for increasing the efficiency and accuracy of early detection of breast cancer for better diagnosis. The thought process involved using a pre-trained model, which already had some weights assigned rather than building the complete model from scratch. This paper mainly focuses on ResNet101 based Transfer Learning Model paired with the ImageNet dataset. The proposed framework provided us with an accuracy of 99.58%. Extensive experiments and tuning of hyperparameters have been performed to acquire the best possible results in terms of classification. The proposed frameworks aims to be an efficient tool for all doctors and society as a whole and help the user in early detection of breast cancer. [ABSTRACT FROM AUTHOR]

Imaging is important in cancer diagnostics. It takes a long period of medical training and clinical experience for radiologists to be able to accurately interpret diagnostic images. With the advance of big data analysis, machine learning and AI-based devices are currently under development and taking a role in imaging diagnostics. If an AI-based imaging device can read the image as accurately as experienced radiologists, it may be able to help radiologists increase the accuracy of their reading and manage their workloads. In this paper, we consider two potential study objectives of a clinical trial to evaluate an AI-based device for breast cancer diagnosis by comparing its concordance with human radiologists. We propose statistical design and analysis methods for each study objective. Extensive numerical studies are conducted to show that the proposed statistical testing methods control the type I error rate accurately and the design methods provide required sample sizes with statistical powers close to pre-specified nominal levels. The proposed methods were successfully used to design and analyze a real device trial. [ABSTRACT FROM AUTHOR]

Due to the high mortality of many cancers and their related diseases, the prediction and prognosis techniques of cancers are being extensively studied to assist doctors in making diagnoses. Many machine-learning-based cancer predictors have been put forward, but many of them have failed to become widely utilised due to some crucial problems. For example, most methods require too much training data, which is not always applicable to institutes, and the complicated genetic mutual effects of cancers are generally ignored in many proposed methods. Moreover, a majority of these assist models are actually not safe to use, as they are generally built on black-box machine learners that lack references from related field knowledge. We observe that few machine-learning-based cancer predictors are capable of employing prior knowledge (PrK) to mitigate these issues. Therefore, in this paper, we propose a generalisable informed machine learning architecture named the Informed Attentive Predictor (IAP) to make PrK available to the predictor's decision-making phases and apply it to the field of cancer prediction. Specifically, we make several implementations of the IAP and evaluate its performance on six TCGA datasets to demonstrate the effectiveness of our architecture as an assist system framework for actual clinical usage. The experimental results show a noticeable improvement in IAP models on accuracies, f1-scores and recall rates compared to their non-IAP counterparts (i.e., basic predictors). [ABSTRACT FROM AUTHOR]

Oral cancer (OC) is a deadly disease with a high mortality and complex etiology. Artificial intelligence (AI) is one of the outstanding innovations in technology used in dental science. This paper intends to report on the application and performance of AI in diagnosis and predicting the occurrence of OC. In this study, we carried out data search through an electronic search in several renowned databases, which mainly included PubMed, Google Scholar, Scopus, Embase, Cochrane, Web of Science, and the Saudi Digital Library for articles that were published between January 2000 to March 2021. We included 16 articles that met the eligibility criteria and were critically analyzed using QUADAS-2. AI can precisely analyze an enormous dataset of images (fluorescent, hyperspectral, cytology, CT images, etc.) to diagnose OC. AI can accurately predict the occurrence of OC, as compared to conventional methods, by analyzing predisposing factors like age, gender, tobacco habits, and bio-markers. The precision and accuracy of AI in diagnosis as well as predicting the occurrence are higher than the current, existing clinical strategies, as well as conventional statistics like cox regression analysis and logistic regression. [ABSTRACT FROM AUTHOR]

Globally, breast cancer is one of the most significant causes of death among women. Early detection accompanied by prompt treatment can reduce the risk of death due to breast cancer. Currently, machine learning in cloud computing plays a pivotal role in disease diagnosis, but predominantly among the people living in remote areas where medical facilities are scarce. Diagnosis systems based on machine learning act as secondary readers and assist radiologists in the proper diagnosis of diseases, whereas cloud-based systems can support telehealth services and remote diagnostics. Techniques based on artificial neural networks (ANN) have attracted many researchers to explore their capability for disease diagnosis. Extreme learning machine (ELM) is one of the variants of ANN that has a huge potential for solving various classification problems. The framework proposed in this paper amalgamates three research domains: Firstly, ELM is applied for the diagnosis of breast cancer. Secondly, to eliminate insignificant features, the gain ratio feature selection method is employed. Lastly, a cloud computing-based system for remote diagnosis of breast cancer using ELM is proposed. The performance of the cloud-based ELM is compared with some state-of-the-art technologies for disease diagnosis. The results achieved on the Wisconsin Diagnostic Breast Cancer (WBCD) dataset indicate that the cloud-based ELM technique outperforms other results. The best performance results of ELM were found for both the standalone and cloud environments, which were compared. The important findings of the experimental results indicate that the accuracy achieved is 0.9868, the recall is 0.9130, the precision is 0.9054, and the F1-score is 0.8129. [ABSTRACT FROM AUTHOR]

The worldwide incidence of skin cancer has risen rapidly in the last decades, becoming one in three cancers nowadays. Currently, a person has a 4% chance of developing melanoma, the most aggressive form of skin cancer, which causes the greatest number of deaths. In the context of increasing incidence and mortality, skin cancer bears a heavy health and economic burden. Nevertheless, the 5-year survival rate for people with skin cancer significantly improves if the disease is detected and treated early. Accordingly, large research efforts have been devoted to achieve early detection and better understanding of the disease, with the aim of reversing the progressive trend of rising incidence and mortality, especially regarding melanoma. This paper reviews a variety of the optical modalities that have been used in the last years in order to improve non-invasive diagnosis of skin cancer, including confocal microscopy, multispectral imaging, three-dimensional topography, optical coherence tomography, polarimetry, self-mixing interferometry, and machine learning algorithms. The basics of each of these technologies together with the most relevant achievements obtained are described, as well as some of the obstacles still to be resolved and milestones to be met. [ABSTRACT FROM AUTHOR]

Early detection of cancer increases the probability of recovery. This paper presents an intelligent decision support system (IDSS) for the early diagnosis of cancer based on gene expression profiles collected using DNA microarrays. Such datasets pose a challenge because of the small number of samples (no more than a few hundred) relative to the large number of genes (in the order of thousands). Therefore, a method of reducing the number of features (genes) that are not relevant to the disease of interest is necessary to avoid overfitting. The proposed methodology uses the information gain (IG) to select the most important features from the input patterns. Then, the selected features (genes) are reduced by applying the grey wolf optimization (GWO) algorithm. Finally, the methodology employs a support vector machine (SVM) classifier for cancer type classification. The proposed methodology was applied to two datasets (Breast and Colon) and was evaluated based on its classification accuracy, which is the most important performance measure in disease diagnosis. The experimental results indicate that the proposed methodology is able to enhance the stability of the classification accuracy as well as the feature selection. [ABSTRACT FROM AUTHOR]